233 related articles for article (PubMed ID: 26563376)
1. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V
Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376
[TBL] [Abstract][Full Text] [Related]
2. Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients.
Annuar AA; Ankathil R; Mohd Yunus N; Husin A; Ab Rajab NS; Abdul Aziz AA; Ibrahim MI; Sulong S
Asian Pac J Cancer Prev; 2021 Feb; 22(2):565-571. PubMed ID: 33639675
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
Daripally S; Nallapalle SR; Katta S; Prasad VV
Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
Cao Y; Miao XP; Huang MY; Deng L; Lin DX; Zeng YX; Shao JY
Mol Carcinog; 2010 Nov; 49(11):944-50. PubMed ID: 20842669
[TBL] [Abstract][Full Text] [Related]
6. [Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer].
Yang S; Miao XP; Zhang XM; Sun T; Qu SN; Xiong P; Ye YJ; Guo YL; Tan W; Wang S; Lin DX
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2132-5. PubMed ID: 16313826
[TBL] [Abstract][Full Text] [Related]
7. Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis.
Kobak Ş; Berdeli A
Reumatismo; 2012 Dec; 64(6):374-9. PubMed ID: 23285481
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.
Zamani AG; Barlas IO; Durakbasi-Dursun G; Ural O; Erdal E; Yildirim MS
Int J Immunogenet; 2013 Dec; 40(6):482-7. PubMed ID: 23560484
[TBL] [Abstract][Full Text] [Related]
9. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.
Jung YJ; Kim YJ; Kim LH; Lee SO; Park BL; Shin HD; Lee HS
Intervirology; 2007; 50(5):369-76. PubMed ID: 17938571
[TBL] [Abstract][Full Text] [Related]
10. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.
Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T
In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between FAS/FASL gene polymorphisms and susceptibility of coal worker's pneumoconiosis].
Ni CH; Song ZF; Jia XM; Li AP; Li CP; Li SK; Li YM; Wang ZL; Zhou Y; Wang SY; Zhang ZD; Zhou JW
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Sep; 25(9):532-6. PubMed ID: 17997887
[TBL] [Abstract][Full Text] [Related]
12. FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer.
Lima L; Ferreira JA; Tavares A; Oliveira D; Morais A; Videira PA; Medeiros R; Santos L
Urol Oncol; 2014 Jan; 32(1):44.e1-7. PubMed ID: 23948181
[TBL] [Abstract][Full Text] [Related]
13. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma.
Zhang W; Li C; Wang J; He C
Hepatogastroenterology; 2012; 59(113):141-6. PubMed ID: 21940365
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of extrinsic death receptor apoptotic genes (FAS -670 G>A, FASL -844 T>C) in coronary artery disease.
Kishore Kumar G; Rajesh Kumar G; Mrudula Spurthi K; Nivas S; Chiranjeevi P; Ali A; Sahu SK; Pratibha N; Surekha Rani H
Apoptosis; 2016 May; 21(5):558-65. PubMed ID: 26922070
[TBL] [Abstract][Full Text] [Related]
15. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.
Zhao H; Chen W; Du P; Sun A; Zhuang C; Tong J; Wang L
Tumour Biol; 2015 Jun; 36(6):4319-26. PubMed ID: 25596086
[TBL] [Abstract][Full Text] [Related]
16. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
[TBL] [Abstract][Full Text] [Related]
17. Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.
Gu D; Du M; Tang C; Chu H; Xu Z; Huo X; Gong W; Tang Y; Zhou J; Tong N; Xu Y; Zhang Z; Wang M; Chen J
Environ Mol Mutagen; 2014 Jun; 55(5):421-7. PubMed ID: 24535941
[TBL] [Abstract][Full Text] [Related]
18. Influence of interferon alpha on expression of Fas and Fas ligand in dendritic cells from patients with chronic myeloid leukemia.
Zhao WL; Chai YH; He HL; Wei XC; Wang T; Xing PN; Li MS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):501-5. PubMed ID: 18549617
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
Hsu PI; Lu PJ; Wang EM; Ger LP; Lo GH; Tsay FW; Chen TA; Yang HB; Chen HC; Lin WS; Lai KH
Anticancer Res; 2008; 28(1A):97-103. PubMed ID: 18383830
[TBL] [Abstract][Full Text] [Related]
20. [Polymorphisms of FAS and FASL genes and susceptibility of silicosis].
Wu F; Qu YB; Sun P; Ji F; Qiu YL; Miao WB; Wang W; Jin RF; Xia ZL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):7-11. PubMed ID: 18302883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]